dc.contributor.author |
Kostyuk, A.
|
|
dc.contributor.author |
Nurgozhin, T.
|
|
dc.contributor.author |
Akanov, A.
|
|
dc.creator |
A., Kostyuk |
|
dc.date.accessioned |
2017-12-15T06:22:23Z |
|
dc.date.available |
2017-12-15T06:22:23Z |
|
dc.date.issued |
2014-11-01 |
|
dc.identifier |
DOI:10.1016/j.jval.2014.08.538 |
|
dc.identifier.citation |
A. Kostyuk, T. Nurgozhin, A. Akanov, PND1 - Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness, In Value in Health, Volume 17, Issue 7, 2014, Pages A808-A809 |
en_US |
dc.identifier.issn |
10983015 |
|
dc.identifier.uri |
https://www.sciencedirect.com/science/article/pii/S1098301514024681 |
|
dc.identifier.uri |
http://nur.nu.edu.kz/handle/123456789/2943 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Value in Health |
en_US |
dc.relation.ispartof |
Value in Health |
|
dc.title |
PND1 Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness |
en_US |
dc.type |
Article |
en_US |
dc.rights.license |
Copyright © 2014 Published by Elsevier Inc. |
|
elsevier.identifier.doi |
10.1016/j.jval.2014.08.538 |
|
elsevier.identifier.eid |
1-s2.0-S1098301514024681 |
|
elsevier.identifier.pii |
S1098-3015(14)02468-1 |
|
elsevier.volume |
17 |
|
elsevier.issue.identifier |
7 |
|
elsevier.coverdate |
2014-11-01 |
|
elsevier.coverdisplaydate |
November 2014 |
|
elsevier.startingpage |
A808 |
|
elsevier.endingpage |
A809 |
|
elsevier.openaccess |
1 |
|
elsevier.openaccessarticle |
true |
|
elsevier.openarchivearticle |
true |
|
elsevier.openaccessuserlicense |
http://www.elsevier.com/open-access/userlicense/1.0/ |
|
elsevier.aggregationtype |
Journal |
|
workflow.import.source |
science |
|